PuSH - Publikationsserver des Helmholtz Zentrums München

Lau, H.H.* ; Gan, S.U.* ; Lickert, H. ; Shapiro, A.M.J.* ; Lee, K.O.* ; Teo, A.K.K.*

Charting the next century of insulin replacement with cell and gene therapies.

Med. 2, 1138-1162 (2021)
DOI PMC
The discovery of insulin a century ago changed the lives of millions of individuals suffering from diabetes, paving the way for long-term survival. While the availability of recombinant insulin for hormone replacement therapy has served extremely well to help control blood glucose in diabetes, there remains significant room for further improvements for an ultimate “cure” for diabetes patients. In this review, we celebrate the 100th anniversary of the discovery of insulin and consolidate the key milestones and advances in the development of recombinant human insulin. We then summarize recent and current technological developments in terms of insulin gene- and cell-replacement therapies that are promising in greater therapeutic potential. We envision that the next era of insulin replacement therapies will effectively treat diabetes and serve our patients even better for the next century to come.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Korrespondenzautor
ISSN (print) / ISBN 2666-6359
e-ISSN 2666-6340
Zeitschrift Med (N Y)
Quellenangaben Band: 2, Heft: 10, Seiten: 1138-1162 Artikelnummer: , Supplement: ,
Verlag Cell Press
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes and Regeneration Research (IDR)